Project 3 - Preclinical Studies
项目 3 - 临床前研究
基本信息
- 批准号:8933618
- 负责人:
- 金额:$ 26.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-15 至
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAdolescentAdultAffectAgeAge of OnsetAgonistAnteriorAreaBrainCigaretteClinicalClinical ResearchDevelopmentDopamineDopamine AntagonistsFemaleFoundationsFutureGenderGlutamate ReceptorGlutamatesGoalsHistamineHistamine H1 AntagonistsHistamine ReceptorHumanIndividualInfusion proceduresMediatingMedicalModelingN-MethylaspartateNicotineNicotine DependenceNicotinic ReceptorsNucleus AccumbensOralPharmaceutical PreparationsPharmacologic SubstancePhasePopulationProcessPsychological reinforcementRattusResearchSelf AdministrationSerotoninSex CharacteristicsSmokerStudy modelsSubgroupSystemTestingTobacco smokingTreatment EfficacyWeight GainWithholding Treatmentaddictionbasecholinergiccingulate cortexdrug developmentearly adolescenceeffective therapyfollow-upindividualized medicineinhibitor/antagonistinnovationmalemonoamineneural circuitneurobehavioralnoradrenergicpre-clinicalpreclinical studyreceptorreuptakesexsmoking cessationsuccesstherapy developmenttranslational studytreatment effect
项目摘要
ABSTRACT: Project 3. Preclinical Studies
The preclinical project in the Center has the purpose of discovering new treatments which have promise for
enhancing success with tobacco smoking cessation and to provide better basic understanding of the
neurobehavioral processes underlying nicotine reinforcement to build a foundation for further treatment
development. In the initial phase of the Center's research effort the preclinical project has provided promising new
leads for medical treatments to aid smoking cessation and important neurobehavioral mechanistic information to
help guide rational drug development for further progress in enhancing smoking cessation therapy. Two of our
discoveries, the efficacy of the serotonin 5HT2c antagonist lorcaserin and the triple monoamine transmitter reuptake
inhibitor amitifadine in significantly reducing nicotine self-administration (SA) will be advanced to human testing in
the clinical project of the Center. Our project will continue this progress in the next phase of the Center's
development. The rat model of nicotine SA will be used to build on our discovery of diverse treatments based on
actions at nicotinic cholinergic, 5HT2c serotonergic, D1 dopaminergic, α2 nordrenergic, H1 histaminergic and NMDA
glutaminergic receptor systems will be followed up in three ways. 1) Combinations of these effective treatments will
be evaluated to discover which would provide added therapeutic efficacy. 2) Differential efficacy of the diverse
treatments will be tested in different subpopulations based on sex, adolescent or later age of onset of nicotine SA,
low vs. high levels of nicotine SA, involvement of oral consummatory aspects of SA and pre or post cessation
liability of nicotine SA. 3) The brain circuit mechanisms for the diverse treatments will be characterized through local
brain area infusions of the different receptor-based treatments to see where the critical loci of actions are for the
successful therapies. These studies will serve to refine the treatments for the tailored and adaptive treatment for
smoking cessation in people. It has become clear that there is unlikely to be a single treatment that reaches all
smokers to enable them to successfully quit. The diverse toolbox of treatments and further understanding of their
mechanisms of action will help provide the clinical studies in our Center and the field in general to advance the goal
of smoking cessation for the full variety of smokers.
摘要:项目3。临床前研究
该中心的临床前项目旨在发现新的治疗方法,
提高戒烟的成功率,并提供更好的基本了解,
尼古丁强化的神经行为过程,为进一步治疗奠定基础
发展在该中心研究工作的初始阶段,临床前项目提供了有希望的新的
帮助戒烟的医学治疗的线索和重要的神经行为机制信息,
有助于指导合理的药物开发,进一步提高戒烟治疗的效果。我们的两
发现,5-羟色胺5 HT 2c拮抗剂氯卡色林和三重单胺递质再摄取的功效
一种抑制剂阿米替丁在显着减少尼古丁自我管理(SA)将提前到人体测试,
中心的临床项目。我们的项目将在中心的下一阶段继续这一进展,
发展尼古丁SA的大鼠模型将用于建立我们发现的基于以下的多种治疗方法:
对烟碱胆碱能、5-HT 2c胆碱能、D1多巴胺能、α2去甲肾上腺素能、H1组胺能和NMDA的作用
多巴胺能受体系统将以三种方式跟进。1)这些有效治疗的组合将
进行评估,以发现哪种药物可以提供额外的治疗效果。2)多样性的不同功效
治疗将在不同的亚群中进行测试,这些亚群基于性别、青少年或尼古丁SA发作的更晚年龄,
低水平与高水平的尼古丁SA,SA的口服消耗方面的参与以及戒烟前后
尼古丁SA的责任3)不同治疗的脑回路机制将通过局部
脑区灌注不同的受体为基础的治疗,看看关键的行动位点是为
成功的治疗这些研究将有助于改进治疗方法,为患者提供量身定制的适应性治疗。
戒烟的人。很明显,不可能有一种单一的治疗方法可以达到所有人,
吸烟者,使他们能够成功戒烟。各种治疗工具箱和进一步了解他们的
作用机制将有助于提供我们中心和一般领域的临床研究,以推进目标
为所有的吸烟者提供戒烟服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD D LEVIN其他文献
EDWARD D LEVIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD D LEVIN', 18)}}的其他基金
International Neurotoxicology Association (INA) Conference
国际神经毒理学协会(INA)会议
- 批准号:
10601313 - 财政年份:2022
- 资助金额:
$ 26.34万 - 项目类别:
Complementary Neurotoxicological Insights from Fish, Flies, Bees and Worms Symposium
来自鱼、苍蝇、蜜蜂和蠕虫研讨会的补充神经毒理学见解
- 批准号:
8986146 - 财政年份:2015
- 资助金额:
$ 26.34万 - 项目类别:
Nicotinic Receptor Desensitization to Reduce Drug Self-Administration
烟碱受体脱敏以减少药物自我给药
- 批准号:
8124477 - 财政年份:2010
- 资助金额:
$ 26.34万 - 项目类别:
Neurobehavioral Teratology Society: Zebrafish Symposium
神经行为畸胎学学会:斑马鱼研讨会
- 批准号:
8004765 - 财政年份:2010
- 资助金额:
$ 26.34万 - 项目类别:
Neurobehavioral Mechanisms of Cognitive Impairment
认知障碍的神经行为机制
- 批准号:
6900495 - 财政年份:2005
- 资助金额:
$ 26.34万 - 项目类别:
Adolescence: A Sensitive Period for Nicotine Addiction
青春期:尼古丁成瘾的敏感期
- 批准号:
6878932 - 财政年份:2004
- 资助金额:
$ 26.34万 - 项目类别:
Adolescence: A Sensitive Period for Nicotine Addiction
青春期:尼古丁成瘾的敏感期
- 批准号:
7213403 - 财政年份:2004
- 资助金额:
$ 26.34万 - 项目类别:
Adolescence: A Sensitive Period for Nicotine Addiction
青春期:尼古丁成瘾的敏感期
- 批准号:
7048534 - 财政年份:2004
- 资助金额:
$ 26.34万 - 项目类别:
相似海外基金
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
- 批准号:
10755168 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
- 批准号:
480840 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
- 批准号:
10744412 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
- 批准号:
23K07305 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
- 批准号:
23H02874 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
- 批准号:
10756652 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
- 批准号:
10730872 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
- 批准号:
10650648 - 财政年份:2023
- 资助金额:
$ 26.34万 - 项目类别: